Stock Scorecard
Stock Summary for Becton Dickinson & Company (BDX) - $194.02 as of 11/28/2025 8:48:09 PM EST
Total Score
11 out of 30
Safety Score
57 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BDX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BDX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BDX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BDX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BDX (57 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 5 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BDX
Financial Details for BDX
Company Overview |
|
|---|---|
| Ticker | BDX |
| Company Name | Becton Dickinson & Company |
| Country | USA |
| Description | Becton, Dickinson and Company (BDX) is a leading American multinational medical technology company renowned for its development and production of critical medical devices, instrument systems, and reagents that significantly improve global healthcare outcomes. With a diversified portfolio that supports a wide array of diagnostic and therapeutic procedures, BDX effectively addresses the evolving needs of the healthcare community while providing analytical and consulting services to enhance its operational footprint. Driven by a robust commitment to innovation, underscored by considerable investments in research and development, BDX is poised to capitalize on emerging trends in the medical technology sector, solidifying its position as a key player in advancing healthcare solutions. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/3/2026 |
Stock Price History |
|
| Last Day Price | 194.02 |
| Price 4 Years Ago | 230.76 |
| Last Day Price Updated | 11/28/2025 8:48:09 PM EST |
| Last Day Volume | 592,823 |
| Average Daily Volume | 2,663,088 |
| 52-Week High | 248.00 |
| 52-Week Low | 161.47 |
| Last Price to 52 Week Low | 20.16% |
Valuation Measures |
|
| Trailing PE | 33.32 |
| Industry PE | 399.77 |
| Sector PE | 89.93 |
| 5-Year Average PE | 17.17 |
| Free Cash Flow Ratio | 86.23 |
| Industry Free Cash Flow Ratio | 42.50 |
| Sector Free Cash Flow Ratio | 29.09 |
| Current Ratio Most Recent Quarter | 1.11 |
| Total Cash Per Share | 2.25 |
| Book Value Per Share Most Recent Quarter | 88.96 |
| Price to Book Ratio | 2.18 |
| Industry Price to Book Ratio | 3.55 |
| Sector Price to Book Ratio | 33.13 |
| Price to Sales Ratio Twelve Trailing Months | 2.55 |
| Industry Price to Sales Ratio Twelve Trailing Months | 45.76 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.04 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 285,419,000 |
| Market Capitalization | 55,376,994,380 |
| Institutional Ownership | 93.79% |
Dividends |
|
| Ex-Dividend Date | 12/8/2025 |
| Previous Dividend Amount | 1.0400 |
| Current Dividend Amount | 1.0500 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 4.16 |
| Trailing Annual Dividend Yield | 2.14% |
| Forward Annual Dividend Rate | 4.20 |
| Forward Annual Dividend Yield | 2.16% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 1.65% |
| 5-Year Average Dividend Yield | 1.55% |
| 1-Year Dividend Growth Rate Percentage | 7.20% |
| 3-Year Dividend Growth Rate Percentage | 6.45% |
| 5-Year Dividend Growth Rate Percentage | 5.55% |
| All-Time Dividend Growth Rate Percentage | 10.49% |
| Dividend Payout Ratio | 71.48% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 25.20% |
| Annual Earnings Growth | -1.58% |
| Reported EPS 12 Trailing Months | 5.82 |
| Reported EPS Past Year | 14.42 |
| Reported EPS Prior Year | 13.16 |
| Net Income Twelve Trailing Months | 1,597,000,000 |
| Net Income Past Year | 1,678,000,000 |
| Net Income Prior Year | 1,705,000,000 |
| Quarterly Revenue Growth YOY | 8.30% |
| 5-Year Revenue Growth | 6.32% |
| Operating Margin Twelve Trailing Months | 17.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 641,000,000 |
| Total Cash Past Year | 851,000,000 |
| Total Cash Prior Year | 1,717,000,000 |
| Net Cash Position Most Recent Quarter | -16,980,000,000 |
| Net Cash Position Past Year | -16,770,000,000 |
| Long Term Debt Past Year | 17,621,000,000 |
| Long Term Debt Prior Year | 17,940,000,000 |
| Total Debt Most Recent Quarter | 17,621,000,000 |
| Equity to Debt Ratio Past Year | 0.59 |
| Equity to Debt Ratio Most Recent Quarter | 0.59 |
| Total Stockholder Equity Past Year | 25,390,000,000 |
| Total Stockholder Equity Prior Year | 25,889,000,000 |
| Total Stockholder Equity Most Recent Quarter | 25,390,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,628,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.21 |
| Free Cash Flow Past Year | 2,670,000,000 |
| Free Cash Flow Prior Year | 3,073,000,000 |
Options |
|
| Put/Call Ratio | 0.18 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 2.27 |
| MACD Signal | 1.14 |
| 20-Day Bollinger Lower Band | 175.14 |
| 20-Day Bollinger Middle Band | 187.83 |
| 20-Day Bollinger Upper Band | 200.52 |
| Beta | 0.28 |
| RSI | 60.64 |
| 50-Day SMA | 197.59 |
| 150-Day SMA | 223.88 |
| 200-Day SMA | 226.90 |
System |
|
| Modified | 11/28/2025 6:35:28 PM EST |